HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


France And Italy Next For Zur Rose As Sales Exceed $1bn For First Time

Executive Summary

France and Italy are next for ambitious European online pharmacy Zur Rose, which has posted annual turnover in excess of $1bn for the first time. 

You may also be interested in...

Zur Rose Steams Ahead With Acquisition-Led Expansion Amid Investor Concerns

Zur Rose adds French online retail platform Doctipharma as two board members resign over “differences of opinion” with regards to the firm's growth strategy.

Phoenix Goes High-Tech With Interactive Pharmacies In The Czech Republic And Digital Apps In Germany

European wholesale and retail giant Phoenix opens innovative pharmacies in the Czech Republic and launches a new app in Germany to meet the challenge of digital disruption.  

Bricks-And-Mortar Pharmacy In The Crosshairs As Zur Rose Aims To Become The Amazon Of European Healthcare

Swiss supply chain disruptor Zur Rose wants to break up the ancient monopoly of European bricks-and-mortar pharmacy and replace it with a tech-driven healthcare offering to rival that of retail giant Amazon, according to a member of the firm’s board, Olaf Heinrich.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts